TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Change in Account Payables came in at -$340000.0 in Q1 2026, down 314.63% YoY from $158409.1 in Q1 2025, and down 398.25% on a QoQ basis from $114000.0 in Q4 2025.
TherapeuticsMD (TXMD) Change in Account Payables (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Change in Account Payables data on file, last reported at -$340000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 314.63% year-over-year to -$340000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$139000.0 (down 475.68% YoY) and the FY2025 annual result came in at $119000.0, down 48.48% from the prior year.
- Change in Account Payables retreated to -$340000.0 in Q1 2026, from $114000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $174000.0 in Q2 2025 to a low of -$818000.0 in Q2 2023.
- A 5-year average of -$196235.3 and a median of -$82000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables sank 946.84% — and 2025, when it soared 4250.0%.
- Tracing TXMD's Change in Account Payables over 5 years: stood at $79000.0 in 2022, then slumped by 946.84% to -$669000.0 in 2023, then jumped by 103.59% to $24000.0 in 2024, then surged by 375.0% to $114000.0 in 2025, then plunged by 398.25% to -$340000.0 in 2026.
- The last three Change in Account Payables figures came in at -$340000.0 (Q1 2026), $114000.0 (Q4 2025), and -$87000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - | 423,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 423,000.00 |
| Jun 30, 2026 | 423,000.00 |
| Mar 31, 2026 | -340,000.00 |
| Mar 31, 2026 | -340,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |